Nektar Therapeutics | NKTR - Pre Tax Profit


Nektar Therapeutics reported $-43.09M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Agios Pharmaceuticals USD -99.11M 9.94M Mar/2026
ALKERMES USD -61.93M 122.3M Mar/2026
Alterity Therapeutics Limited AUD -6.26M 1.52M Dec/2025
Amgen USD 2.08B 570M Mar/2026
Baxter International USD 362M 368M Jun/2026
BioCryst Pharmaceuticals USD 248.02M 235.89M Dec/2025
Biogen USD 647.3M 269.6M Jun/2026
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
Cara Therapeutics USD -6.8M 1.9M Mar/2026
Cipla INR 10.82B 3.33B Jun/2026
Dr.Reddys Laboratories INR 5.54B 955M Jun/2026
Eisai JPY 25.28B 33.22B Jun/2026
Eli Lilly USD 8.85B 583.8M Mar/2026
Exelixis USD 262.68M 5.01M Jun/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Grifols EUR 257.85M 190.87M Dec/2024
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Incyte USD 751.51M 407.91M Jun/2026
Ionis Pharmaceuticals USD -114M 21M Jun/2026
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
Karyopharm Therapeutics USD -22.39M 17.51M Mar/2026
MacroGenics USD -36.77M 21.84M Mar/2026
Merck USD -3.53B 6.95B Mar/2026
Nektar Therapeutics USD -43.09M 8.39M Mar/2026
Neurocrine Biosciences USD 246.8M 7.4M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Pfizer USD -653M 5.84B Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sarepta Therapeutics USD -1.75M 344.92M Jun/2026
Takeda JPY 162.72B 215.2B Jun/2026
Teva Pharmaceutical Industries USD -455M 1.21B Jun/2026
Xencor USD -21.92M 106.72M Jun/2026